| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | ISHARES TR | 625 | 69 | 80.23% | ||
| 2 | PDL BIOPHARMA INC | 19 | 17 | 19.77% | PRN |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001085146-15-002299, filed 2015.11.13).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.